Renal venous thrombosis in neonates: Prothrombotic risk factors and long-term follow-up

Blood

Volumn 104, Issue 5, 2004, Pages 1356-1360

  Kosch, Andrea ^a   Kuwertz Bröking, Eberhard ^b   Heller, Christine ^b   Kurnik, Karin ^b   Schobess, Rosemarie ^b   Nowak Göttl, Ulrike ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; CARDIOLIPIN ANTIBODY; HOMOCYSTEINE; LIPOPROTEIN A; PROTEIN C; PROTEIN S; PROTHROMBIN;

ARTICLE; CALCULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; FOLLOW UP; GENE MUTATION; HUMAN; HYPERTENSION; KIDNEY VEIN THROMBOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEWBORN; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; THROMBOSIS;

EID: 4444373017     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-01-0229     Document Type: Article

References (33)

1. Bökenkamp A, von Kries R, Nowak-Göttl U, Göbel U, Hoyer PF. Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcome. Eur J Pediatr. 2000;59:44-48.
2. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995;96:939-945.
3. Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child. 1997;76:F163-F167.
4. Jobin J, O'Regan SO, Morgeau JG, Robitaille P. Neonatal renal vein thrombosis-long-term follow-up after conservative management. Clin Nephrol. 1982;17:36-40.
5. Reimold EW, Wittel RA. Renal venous thrombosis in children; changes in management. South Med J. 1983;76:1277-1284.
6. Hibbert J, Howlett DC, Greenwood KL, MacDonald LM, Saunders AJS. The ultrasound appearances of neonatal renal vein thrombosis. Br J Radiol. 1997;70:1191-1194.
7. Keating MA, Althausen AF. The clinical spectrum of renal vein thrombosis. J Urol. 1985;133:938-945.
8. Cozzolino DJ, Cendron M. Bilateral renal vein thrombosis in a newborn: a case of prenatal renal vein thrombosis. Urology. 1997;50:128-131.
9. Nowak-Göttl U, Junker R, Hartmeier M, et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation. 1999;100:743-748.
10. Nowak-Göttl U, Wermes C, Junker R, et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin 20210G>A variant, and further prothrombotic risk factors. Blood. 1999;93:1595-1599.
11. Nowak-Göttl U, Junker R, Kreuz W, et al. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood. 2001;97:858-862.
12. Günther G, Junker R, Sträter R, et al. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke. 2000;31:2437-2441.
13. Heller C, Schobess R, Kurnik K, et al. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. Br J Haematol. 2000;111:534-539.
14. Kosch A, Junker R, Kurnik K, et al. Thrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study. Thromb Res. 2000;99:531-537.
15. Giordano P, Laforgia N, Di Giulio G, Storelli S, Mautone A, Iolascon A. Renal vein thrombosis in a newborn with prothrombotic genetic risk factors. Perinat Med. 2001;29:163-166.
16. Leret N, Cortey A, Maillard C, et al. Neonatal renal vein thrombosis in a heterozygous carrier of both factor V Leiden and prothrombin mutations. Arch Pediatr. 2001;8:1222-1225.
17. Deeg KH, Nagler B, Schönau E, Ruder H. Farbkodierte Doppler-Sonographie der Nierengefäße im Kindesalter. Monatsschr Kinderheilkd. 1990;138:337-348.
18. Manco-Johnson M, Nuss R, Hays T, Krupski W, Drose J, Manco-Johnson ML. Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr. 2000;136:446-453.
19. Farnoux C, Camard O, Pinquier D, et al. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr. 1998;133:137-140.
20. Heller C, Heinecke A, Junker R, et al. Cerebral venous thrombosis in children. Circulation. 2003;108:1362-1367.
21. Junker R, Koch HG, Auberger K, Münchow N, Ehrenforth S, Nowak-Göttl U. Prothrombin 20210G&A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Thromb Vasc Biol. 1999;19:2568-2572.
22. Ehrenforth S, Junker R, Koch HG, et al. Multicentre evaluation of combined prothrombotic defects associated with thrombophilla in childhood. Childhood Thrombophilia Study Group. Eur J Pediatr. 1999;158(suppl 3):S97-S104.
23. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422:43-52.
24. Kosch A, Koch HG, Heinecke A, Kurnik K, Heller C, Nowak-Göttl U. Increased fasting homocysteine plasma levels as risk factor for thromboembolism in children. Thromb Haemost. 2004;91:308-314.
25. Mocan H, Beattie TJ, Murphy AV. Renal venous thrombosis in infancy: long-term follow-up. Pediatr Nephrol. 1991;5:45-49.
26. Report of the second task force on blood pressure control in children: 1987. Pediatrics. 1987;79:1-25.
27. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Ped Clin North Am. 1987;34:571-590.
28. Nowak-Göttl U, Auberger K, Halimeh S, et al. Thrombolysis in newborns and infants. Thromb Haemost. 1999;82:112-116.
29. Arneil GC. Renal venous thrombosis. Contrib Nephrol. 1979;15:21-29.
30. Keidan I, Lotan D, Gazit G, Boichis H, Reichman B, Linder N. Early neonatal renal venous thrombosis: long-term outcome. Acta Paediatr. 1994;83:1225-1227.
31. Nuss R, Hays T, Manco-Johnson M. Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. Am J Pediatr Hematol Oncol. 1994;16:127-131.
32. Siegbahn A, Ruusuvaara L. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Thromb Haemost. 1988;60;361-364.
33. Sträter R, Becker S, von Eckardstein A, et al. Prospective assessment of risk factors for recurrent stroke during childhood: a 5-year follow-up study. Lancet. 2002;360:1526-1527.